Menu
Search
Home > Courses > HCV & HIV/HCV Management Update for HIV Primary Care Providers

HCV & HIV/HCV Management Update for HIV Primary Care Providers

HCV & HIV/HCV Management Update for HIV Primary Care Providers
Play
Sorry, this learning module is not available for mobile devices.
COPYRIGHT: Videos of live meetings of PRN in NYC are owned and published by Physicians' Research Network, Inc. Copyright © 2017. All rights reserved.
COLLABORATION STATEMENT: The AIDS Institute is proud of the ongoing collaboration between the Clinical Education Initiative (CEI) and Physicians Research Network (PRN). Founded in 1990, PRN has a well-established reputation for spotlighting the work of the most innovative and influential leaders in the HIV treatment, prevention and research fields through its monthly meetings in New York City. Since 2010, CEI has featured recordings of PRN's monthly events through the CEI website. The combined efforts of both educational institutions have enhanced the continuing educational resources available to New York State clinicians caring for people living with, or at risk for HIV.
Original Release Date: 6/20/2017
Review Date: 10/30/2017
Presenter
  • Andrew J Muir, MD
    Professor of Medicine
    Duke University School of Medicine
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Understand risk of liver morbidity following HCV treatment.
  2. Appreciate strategies for evaluation of fibrosis.
  3. Be aware of upcoming therapies for HCV.
Presenter Bio
Andrew Muir, MD
Dr. Muir attended Trinity University in San Antonio, Texas for his undergraduate education, which was followed by medical school at Duke University. He went on to complete his internal medicine residency and gastroenterology fellowship at Duke, and joined the faculty in the Division of Gastroenterology at Duke in 2000. He joined the faculty at DCRI and worked closely with his mentor, Dr. John McHutchison, to establish the Gastroenterology and Hepatology Research program at the DCRI. Through his work at the DCRI, Dr. Muir has participated in the development programs of many of the direct acting antiviral agents that have revolutionized hepatitis C care. He assumed the leadership of the Gastroenterology and Hepatology Research program at DCRI in 2010 and has expanded the research portfolio to include other liver disorders and gastroenterology outcomes. In addition to his achievements as a clinician and researcher, Dr. Muir has also received acclaim for his teaching at Duke, where he has received the Golden Apple Teaching Award, the Eugene A. Stead, Jr. Teaching Award, the Joseph Greenfield, Jr., MD Mentor Award, and the Paul Killenberg Teaching Award.
Continuing Education Credit (The CE accreditation for this course has expired - this section is only for your information)

This CME activity was approved for AMA PRA Category 1 Credit™ on June 20, 2017 and will terminate June 19, 2020.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Muir (Presenter) had the following personal financial relationships in the prior 12 months with manufacturers of the products or services that may be presented in this CME activity: Grant or contract supports research and university salary, and consulting with Merck, BMS, Janssen, AbbVie, and Gilead; Advisory Board of AbbVie, and Gilead.  Dr. Muir submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature 

Financial Support

This meeting of the Physicians' Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

Details:

This online video and post-activity evaluation are one hour in length. 

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules